The Friedreich’s Ataxia Research Alliance (FARA) serves as a catalyst in public, private, scientific and patient-family communities, to build worldwide support and collaborations that drive medical research advances for Friedreich’s ataxia.
more
Newsletter
SCIENTIFIC NEWS
FIVE NEW RESEARCH PUBLICATIONS WEEK OF AUGUST 25, 2008.
- Predictors of progression in patients with Friedreich ataxia.
- Neurological effects of recombinant human erythropoietin in Friedreich's ataxia: A clinical pilot trial.
- In vivo imaging of pyrrole-imidazole polyamides with positron emission tomography
UPCOMING EVENTS
- Sep 13 2008
Crab Feed
Citrus Heights, CA - Sep 20 2008
Ride Ataxia III Martinez Fundraiser
Martinez, CA - Sep 20-21 2008
Simpson Triathalon
Rye, New York
nrs17@columbia.edu - Sep 22 2008
Olsen Golf Tournament
Monroe Township, New Jersey
danosee@comcast.net
FARA NEWS
- BGC Partners, Inc. Selects the Friedreich's Ataxia Research Alliance as a Charity Day Recipient
- Repligen Receives Research Grants to Support Friedreich's Ataxia Development Program
- Save the Date—December 6, 2008 Friedreich's Ataxia Symposium presented by The Children's Hospital of Philadelphia.
- $250,000 in Kyle Bryant Translational Research Awards Announced Today
- Canada First to Approve Drug in Friedreich’s Ataxia
- Keeping Kids Healthy Living with Friedreich’s Ataxia
Online grant submission allows for faster evaluation and approval of applications.
Listings of ongoing trials -
Join the Patient Registry which matches patients to the appropriate clinical trials.
You can have an impact on research advancement by providing critical funds. REQUEST KIT